Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
NCT02099370 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2020-04-03
Summary
The investigators are measuring the adherence rates of an oral MS drug that is to be administered twice-daily. The investigators would like to observe any patterns that might indicate factors that greatly affect adherence.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of South Florida
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- United States
Study Locations
More Related Trials
-
The Use of Technology to Improve MS Clinical Trials and Patient Care
NCT02454907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development of a Motivational Intervention to Improve Treatment Adherence in MS
NCT01925690 ·Status: COMPLETED ·Phase: NA
-
Tecfidera Slow-Titration Study
NCT02428231 ·Status: TERMINATED ·Phase: PHASE3
-
Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS
NCT02218879 ·Status: TERMINATED
-
Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece
NCT03101735 ·Status: COMPLETED
-
Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis
NCT01080573 ·Status: COMPLETED
-
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
NCT02097849 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence Trial With MS LifeLines ® Services
NCT01905527 ·Status: TERMINATED
-
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
NCT01071512 ·Status: COMPLETED ·Phase: NA
-
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
NCT07222618 ·Status: RECRUITING
-
Profile of Adherence to Therapy and Interventions to Promote Adherence in MS
NCT02488343 ·Status: UNKNOWN ·Phase: NA
-
Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera
NCT02410278 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS
NCT02419638 ·Status: WITHDRAWN
-
Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate
NCT02090348 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparative Oral Bioavailability Study of MT-1303
NCT02310048 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone
NCT00240006 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects
NCT00292253 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
NCT06897657 ·Status: COMPLETED
-
Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers
NCT02683863 ·Status: COMPLETED ·Phase: PHASE4
-
A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS)
NCT02846558 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
NCT01903291 ·Status: COMPLETED
-
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
NCT00349193 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
NCT05949580 ·Status: RECRUITING
-
Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera
NCT04756687 ·Status: COMPLETED
-
Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS
NCT02675413 ·Status: WITHDRAWN ·Phase: PHASE4